Peter Beardsley

发表

Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group.

S. Lipshultz, M. Devidas, M. Bernstein, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.